TheProfitWatch

SMMT - Summit Therapeutics Inc. Common Stock

Day 1m 10m 60m PreMarket Market AfterHours Gap
22.14 0.49 (2.21%) --- --- 0.08 (0.35%) -0.14 (-0.63%) 0.44 (1.98%) 0.03 (0.13%) 0.03 (0.13%)

Summit Therapeutics Inc is a biopharmaceutical company that focuses on the discovery, development, and commercialization of novel antibiotics for serious infectious diseases. Its CDI (Clostridiodes difficile infection) product candidate is ridinilazole, an orally administered small molecule antibiotic. It has two geographical segments: the United States and the United Kingdom.

Category: PHARMACEUTICAL PREPARATIONS
Market Period: Closed

Earnings & Ratios

Basic EPS:
-0.76
Diluted EPS:
-0.76
Basic P/E:
-29.7763
Diluted P/E:
-29.7763
RSI(14) 1m:
44.35
VWAP:
22.63
RVol:
0.5904

Events

Period Kind Movement Occurred At
10m Price increase 10m 22.88 +0.67 (+3.02%) Oct 15 09:35
1m Price increase 1m 22.38 +0.23 (+1.06%) Oct 15 09:32

Related News